DeepBioInsights aims to dramatically improve the drug design process with the use of AI and Enhanced Deep sampling methods in order to shorten the costs and time needed for new drug approval. We also build genetic toolkits for precision medicine to speed up the diagnosis procedure by designing advanced medical decision systems to assess the treatment response and possible outcome of side-effects. Integration of different types of data is imperative to have more robust decision-making procedures through the design and deployment of intelligent expert systems.